通过与ATF2相互作用,KRM2促进细胞癌的进展,并抑制铁亡
Fang Liu1, Mengtong Wang2, Gao Li2
1Department of Nephrology & Rheumatology and Immunology, Beijing Chao-Yang Hospital/Capital Medical University, Beijing, 100043, China.
Experimental cell research
|March 8, 2025
概括
含有Kringle的跨膜蛋白2 (KRM2) 促进细胞癌 (RCC) 的进展. 通过调节RCC中的ATF2,KRM2增强了瘤生长,增殖,迁移,并通过调节RCC中的ATF2抑制了细胞亡和铁亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在细胞癌 (RCC) 中,含有圆环的跨膜蛋白2 (KRM2) 的功能尚不清楚.
- 调查KRM2的作用对于理解RCC的发病过程至关重要.
研究的目的:
- 阐明KRM2在调节RCC进展中的机制性作用.
- 确定KRM2表达和RCC的临床特征之间的关系.
主要方法:
- 在RCC组织中使用组织微阵列进行KRM2表达分析.
- 在体外研究涉及KRM2和ATF2在RCC细胞系的淘汰/过度表达.
- 在裸体小鼠中的体内瘤异种移植模型.
- 基因表达微阵列,共免疫沉降和循环赫西米德脉冲追踪测试以确定下游目标.
主要成果:
- 在RCC组织中,KRM2表达显著升高,与瘤大小,等级,阶段,透和患者年龄相关.
- 在RCC中,抑制KRM2抑制了瘤生长,增殖,迁移,并促进了亡和铁亡.
- KRM2积极调节ATF2的表达,ATF2的淘汰扭转了KRM2的致癌作用.
结论:
- 在RCC中,KRM2充当瘤基因,促进瘤进展和铁亡.
- KRM2通过调节其下游目标ATF2来发挥其作用.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Electron Transport Chain: Complex I and II
10.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.0K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K


